Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 1/2 7Phase 2 6Phase 1 5Phase 4 2Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Gynecologic 1

Conditions

Ovarian Neoplasms 45Uterine Cervical Neoplasms 24Endometrial Neoplasms 24Fallopian Tube Neoplasms 18Breast Neoplasms 13Pancreatic Neoplasms 7Carcinoma, Ovarian Epithelial 7Uterine Cervical Dysplasia 6Sarcoma 6Lung Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Colonic Neoplasms 5Stomach Neoplasms 4Melanoma 4Head and Neck Neoplasms 4Brain Neoplasms 4Uterine Neoplasms 3Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Liver Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Turcot syndrome 2Triple Negative Breast Neoplasms 2Recurrence 2Rectal Neoplasms 2Peritoneal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Oropharyngeal Neoplasms × Gynecologic × Clear all
NCT04630353 2025-09-12

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Hookipa Biotech GmbH

Phase EARLY_PHASE1 Terminated
10 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡